Literature DB >> 31526348

Caspase-1 as Molecular Key in Cardiac Remodeling during Cardiorenal Syndrome Type 3 in the Murine Model.

Mayra Trentin-Sonoda1,2, Frayli Maltoni Fratoni1, Carolina Victoria da Cruz Junho1, Wellington Caio Silva1, Karine Panico1, Marcela Sorelli Carneiro-Ramos1.   

Abstract

BACKGROUND: Renal ischemia/reperfusion induces a systemic inflammatory response that is directly related to the development of cardiac hypertrophy due to cardiorenal syndrome type 3. Classic inflammatory pathways have been extensively investigated in cardiovascular diseases, including the participation of inflammasome in caspase-1-dependent IL-1β cleavage.
OBJECTIVE: In this study, we aimed to understand how lack of caspase-1 would impact the hypertrophic and apoptotic response in the heart after renal ischemia/reperfusion.
METHODS: Wildtype and caspase-1 knockout animals were submitted to a renal ischemia/reperfusion protocol. Briefly, left kidney ischemia was induced in male C57BL/6 mice for 60 min, followed by reperfusion for 15 days. Gene expression was analysed by Real-Time PCR. Caspase activity was also evaluated.
RESULTS: Lack of caspase-1 led to a more pronounced cardiac hypertrophy in mice subjected to renal ischemia-reperfusion. Such hypertrophic process was accompanied by increased activity of caspase3/7 and 9, indicating apoptosis initiation in an IL-1β- independent manner.
CONCLUSION: Our data corroborate important findings on the role of caspase-1 in the development of cardiac hypertrophy and remodeling. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Apoptosis; cardiac hypertrophy; cardiorenal syndrome; caspase-1; inflammation; renal injury.

Year:  2019        PMID: 31526348     DOI: 10.2174/1566524019666190916153257

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  4 in total

1.  Caspase-1 Abrogates the Salutary Effects of Hypertrophic Preconditioning in Pressure Overload Hearts via IL-1β and IL-18.

Authors:  Fangjie Dai; Xuan Li; Xia Li; Zhiwen Ding; Ran Xu; Peipei Yin; Shijun Wang; Junbo Ge; Jian Wu; Yunzeng Zou
Journal:  Front Mol Biosci       Date:  2021-03-24

2.  Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C.

Authors:  Raquel Silva Neres-Santos; Carolina Victoria Cruz Junho; Karine Panico; Wellington Caio-Silva; Joana Claudio Pieretti; Juliana Almeida Tamashiro; Amedea Barozzi Seabra; César Augusto João Ribeiro; Marcela Sorelli Carneiro-Ramos
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

Review 3.  Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?

Authors:  Daniel Patschan; Benedikt Marahrens; Monique Jansch; Susann Patschan; Oliver Ritter
Journal:  J Clin Med Res       Date:  2022-01-29

4.  Characterization of the Oxidative Stress in Renal Ischemia/Reperfusion-Induced Cardiorenal Syndrome Type 3.

Authors:  Wellington Caio-Silva; Danielle da Silva Dias; Carolina Victoria Cruz Junho; Karine Panico; Raquel Silva Neres-Santos; Milena Trevisan Pelegrino; Joana Claudio Pieretti; Amedea Barozzi Seabra; Kátia De Angelis; Marcela Sorelli Carneiro-Ramos
Journal:  Biomed Res Int       Date:  2020-10-09       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.